share_log

Assessing Ingevity: Insights From 5 Financial Analysts

Assessing Ingevity: Insights From 5 Financial Analysts

评估ingevity:5位金融分析师的见解
Benzinga ·  07/11 16:00
In the preceding three months, 5 analysts have released ratings for Ingevity (NYSE:NGVT), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中,有5位分析师发布了Ingevity(纽约证券交易所代码:NGVT)的评级,提出了从看涨到看跌的各种观点。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表总结了他们最近的评估,说明了过去30天不断变化的情绪,并将其与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $55.2, a high estimate of $62.00, and a low estimate of $45.00. Observing a 7.81% increase, the current average has risen from the previous average price target of $51.20.
分析师分析的12个月目标股价提供了见解,平均目标价为55.2美元,最高估计为62.00美元,低估值为45.00美元。目前的平均价格上涨了7.81%,已从之前的平均目标价51.20美元上涨。
Decoding Analyst Ratings: A Detailed Look
解码分析师评级:详细介绍
The standing of Ingevity among financial experts is revealed through an...
通过对分析师近期行为的...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发